scanCOVID-19

REGISTROS MAIS RECENTES

Preprint

Os dados são atualizados diariamente a partir das seguintes fontes: 

medrxiv.org

biorxiv.org

arxiv.org

www.ssrn.com/index.cfm/en/

https://preprints.scielo.org/index.php/scielo

Busque por termos

Selecione ao lado o filtro desejado:

Últimos registros

Abaixo os últimos 30 registros encontrados em nossa base de dados.

Digite um termo acima para filtrar sua busca na tabela abaixo.

Repositório Título Autores Data URL
medrxivDifferential symptoms among COVID-19 outpatients before and during periods of SARS-CoV-2 Omicron variant dominance in Blantyre, Malawi: a prospective observational studyMarah Grace Chibwana, ...2022-07-17
medrxivInfluence of vitamin D supplementation on SARS-CoV-2 vaccine efficacy and immunogenicityDavid A Jolliffe, ...2022-07-17
medrxivEfficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: A protocol for a multicenter, randomized, double-blind, placebo-controlled, phase 3 study (the SCORPIO-SR trial)Hiroshi Yotsuyanagi, ...2022-07-17
medrxivFrom The Plague Horrors of Cholera, What Partnership Lessons Can Be Learnt in Addressing COVID-19 In ZambiaPEVIOUS CHOTA, ...2022-07-17
biorxivSystematic functional interrogation of SARS-CoV-2 host factors using Perturb-seqSara Sunshine, ...2022-07-17
medrxivAttitudes toward COVID-19 pandemic among fully vaccinated individuals: evidence from Greece two years after the pandemicPetros A Galanis, ...2022-07-17
medrxivExtended compartmental model for modeling COVID-19 epidemic in SloveniaMiha Fosnaric, ...2022-07-17
biorxivNovavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineagesJinal Nomathemba Bhiman, ...2022-07-17
medrxivCOVID-19 Prevention at Institutions of Higher Education, United States, 2020 -- 2021: Implementation of Nonpharmaceutical InterventionsSarah Moreland, ...2022-07-17
medrxivInternet-based Cognitive Behaviour Therapy for the Prevention, Treatment and Relapse Prevention of Eating Disorders: A Systematic ReviewNilima Hamid2022-07-17
biorxivIdentification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platformDenisa Bojkova, ...2022-07-17
medrxivEthnic homophily affects vaccine prioritization strategiesClaus Kadelka, ...2022-07-17
medrxivCorrelates of protection for booster doses of the BNT162b2 vaccineTomer Hertz, ...2022-07-17
medrxivAssessment of COVID-19 hospitalization risk during SARS-CoV-2 Omicron relative to Delta variant predominance, New York City, August 2021-January 2022Sharon K. Greene, ...2022-07-17
medrxivAnalysis of SARS-CoV-2 amino acid mutations in New York City Metropolitan wastewater (2020-2022) reveals multiple traits with human health implications across the genome and environment-specific distinctionsArchana Anand, ...2022-07-17
medrxivGlobal patterns and drivers of influenza decline during the COVID-19 pandemicFrancesco Bonacina, ...2022-07-17
medrxivBA.4/BA.5 early surge report AustriaAlexander Gamisch, ...2022-07-15
medrxivDetection of pneumococcus during hospitalization for SARS-CoV-2Anne E Watkins, ...2022-07-15
medrxivVaccine, Booster and Natural Antibody Binding to SARS-CoV-2 Omicron (BA.1) Spike Protein and Vaccine EfficacyPhilip H James-Pemberton, ...2022-07-15
biorxivSARS-CoV-2 BA.4 infection triggers more cross-reactive neutralizing antibodies than BA.1Simone Richardson, ...2022-07-15
medrxivGenome evolution and early introductions of the SARS-CoV-2 Omicron Variant in MexicoHugo Castelan-Sanchez, ...2022-07-15
medrxivTherapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: Findings from a Mendelian randomisation studyFergus W Hamilton, ...2022-07-15
biorxivA zebrafish model of COVID-19-associated cytokine storm syndrome reveals that the Spike protein signals via TLR2Sylwia D Tyrkalska, ...2022-07-15
medrxivMental health of pregnant women during the SARS-CoV-2 pandemic in France: evolution of self-perceived psychological state during the first lockdown, and anxiety frequency two months after the lockdown ended.Alexandra Doncarli, ...2022-07-15
medrxivApplication of Carleman approximants for the estimation of epidemic parameters from incidence data time-seriesJuan C. Muñoz-Sánchez, ...2022-07-15
medrxivSARS-CoV-2 exhibits extreme differences in early viral loads among specimen types suggesting improved detection of pre-infectious and infectious individuals using combination specimen typesAlexander Viloria Winnett, ...2022-07-15
medrxivExtreme differences in SARS-CoV-2 Omicron viral loads among specimen types drives poor performance of nasal rapid antigen tests for detecting presumably pre-infectious and infectious individuals, predicting improved performance of combination specimen antigen testsAlexander Viloria Winnett, ...2022-07-15
biorxivLasting alterations in monocyte and dendritic cell subsets in individuals after hospitalization for COVID-19Francis R. Hopkins, ...2022-07-15
medrxivAssessing Risk Exposure of COVID-19 in Indonesian Government-owned Public Health Center PhysiciansAnton Suryatma, ...2022-07-15
medrxivTracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its borderJordan Douglas, ...2022-07-15
Acompanhe conosco outras fontes importantes sobre covid-19 do Brasil
https://covid.saude.gov.br/

Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. Diariamente, o Ministério da Saúde, por meio da Secretaria de Vigilância em Saúde (SVS/MS) divulga dados consolidados sobre o COVID-19. Saiba mais sobre o painel.

https://bigdata-covid19.icict.fiocruz.br/

Este projeto utiliza recursos computacionais e cientistas de dados da Plataforma de Ciência de Dados aplicada à Saúde do Laboratório de Informação em Saúde do Icict da Fiocruz (PCDaS), hospedada no Laboratório Nacional de Computação Científica (LNCC).

Campus Sede:

Av. Brasil, 4365 – Manguinhos, Rio de Janeiro – CEP: 21040-900 – Tel: (0xx21) 2598-4242

Este portal é regido pela Política de Acesso Aberto ao Conhecimento, que busca garantir à sociedade o acesso gratuito, público e aberto ao conteúdo integral de toda obra intelectual produzida pela Fiocruz.

© COPYRIGHT / Todos os direitos reservados ao Laboratório de Informação Científica e Tecnológica em Saúde – LICTS / FIOCRUZ